Please login to the form below

Not currently logged in
Email:
Password:

Multidrug resistant infection

This page shows the latest Multidrug resistant infection news and features for those working in and with pharma, biotech and healthcare.

FDA green lights study of phage-based drug for resistant infections

FDA green lights study of phage-based drug for resistant infections

Possible alternative to conventional antibiotics. With multidrug resistant (MDR) infections on the rise worldwide, researchers have started looking at using bacteriophages – viruses that only infect bacteria – as an alternative to a ... alongside

Latest news

  • Tackling the TB threat

    However, the continued health, social and economic problems that the disease poses, alongside the emergence of multidrug-resistant forms and rising infection rates in the developed world, have renewed interest in ... A complication is the emergence of

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics